Markets / ETFs / Sector & theme
Nippon India Mutual Fund · Exchange traded fund tracking Nifty Pharma TRI
Loading the chart…
From the ETF's own traded prices (NSE), to the live price. Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.
| Share of fund | 30 Sept 2026 | 31 Aug 2026 | Change |
|---|---|---|---|
| Stocks held | 99.9% | 100.0% | -0.01 |
| Short positions | -0.1% | -0.0% | -0.11 |
| Cash & others | 0.1% | 0.1% | +0.01 |
| Top 10 stocks | 78.2% | 78.8% | -0.66 |
| Number of stocks | 20 | 20 | 0 |
Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.
| Holding | % of fund |
|---|---|
| Sun Pharmaceutical Industries Limited INE044A01036 | 19.50% |
| Divi's Laboratories Limited INE361B01024 | 11.97% |
| Laurus Labs Limited INE947Q01028 | 7.82% |
| Cipla Limited INE059A01026 | 7.68% |
| Dr. Reddy's Laboratories Limited INE089A01031 | 7.62% |
| Torrent Pharmaceuticals Limited INE685A01028 | 7.16% |
| Lupin Limited INE326A01037 | 5.00% |
| Aurobindo Pharma Limited INE406A01037 | 4.69% |
| Glenmark Pharmaceuticals Limited INE935A01035 | 3.56% |
| Alkem Laboratories Limited INE540L01014 | 3.16% |
| Zydus Lifesciences Limited INE010B01027 | 2.92% |
| Mankind Pharma Limited INE634S01028 | 2.88% |
| IPCA Laboratories Limited INE571A01038 | 2.71% |
| Biocon Limited INE376G01013 | 2.62% |
| Gland Pharma Limited INE068V01023 | 2.34% |
| Sai Life Sciences Limited INE570L01029 | 2.14% |
| Wockhardt Limited INE049B01025 | 1.77% |
| Ajanta Pharma Limited INE031B01049 | 1.67% |
| Abbott India Limited INE358A01014 | 1.43% |
| Piramal Pharma Limited INE0DK501011 | 1.30% |
| Holding | % of fund |
|---|---|
| Net Current Assets | -0.12% |
| Holding | % of fund |
|---|---|
| Triparty Repo | 0.18% |
From the fund house's monthly portfolio (mf.nipponindiaim.com), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.
| ETF | Expense | 1 year |
|---|---|---|
| ICICI Prudential Nifty Pharma ETF | 5.74% | – |
| Nippon India Nifty Pharma ETF | – | +26.01% |
Sorted by expense ratio. The same index should give nearly the same return; costs and how easily you can trade make the difference.
| Symbol (NSE) | PHARMABEES |
| ISIN | INF204KC1089 |
| Tracks | Nifty Pharma TRI |
| Benchmark (scheme document) | Nifty Pharma TRI |
| Fund house | Nippon India Mutual Fund |
| Listed on NSE | 7 Jul 2021 |
| Price history from | 7 Jul 2021 |
| Fund page | Nippon India Nifty Pharma ETF - Regular Plan - Growth › |
List and prices from NSE; expense ratio, fund size, NAV and holdings from AMFI and the fund house's filings.
Prices from NSE; expense ratio, NAV, fund size and holdings from AMFI and the fund house. Information only, not investment advice.
₹28.68 (+0.95% today), from NSE (live).
Nifty Pharma TRI. Its price should follow that index, less its costs.
+26.01% over the last year, from its traded prices.
Through any stockbroker with a demat account, on NSE, like a share. The minimum is one unit.